ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BAYN Bayer AG

28.57
-0.715 (-2.44%)
16 May 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type
Bayer AG TG:BAYN Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.715 -2.44% 28.57 28.50 28.64 29.815 28.50 29.39 367,808 22:50:04

Bayer Lifts 2022 Guidance But Impairments, Charges Weigh on 2Q Earnings

04/08/2022 7:41am

Dow Jones News


Bayer (TG:BAYN)
Historical Stock Chart


From May 2022 to May 2024

Click Here for more Bayer Charts.
   By Cecilia Butini 
 

Bayer AG on Thursday lifted its guidance for the full year after a sales beat in the second quarter and a boost from positive currency effects, though it posted a net loss for the quarter and said it took on some impairments and litigation-related charges.

The German pharmaceutical-and-agricultural company posted a net loss of 298 million euros ($303 million) for the second quarter, narrowed from a loss of EUR2.34 billion the year prior, when profits were affected by the setting aside of provisions to continue litigation on its Roundup weedkiller.

Earnings before interest and taxes swung to EUR169 million from a loss before interest and taxes of EUR2.28 billion the year prior. Bayer said the metric was hit by net special charges of EUR2.11 billion including impairment losses related to its agricultural division. Other special charges were related to continuing litigation and restructuring measures.

Sales for the quarter beat consensus expectations, rising to EUR12.82 billion from EUR10.85 billion the year prior, mainly driven by gains in its Crop Science and Consumer Health division, Bayer said.

The company lifted its 2022 guidance, saying it now expects to generate sales of between EUR47 billion and EUR48 billion, and earnings before interest, taxes, depreciation and amortization before special items of EUR12.5 billion, having previously guided for around EUR12 billion.

 

Write to Cecilia Butini at cecilia.butini@wsj.com

 

(END) Dow Jones Newswires

August 04, 2022 02:26 ET (06:26 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

1 Year Bayer Chart

1 Year Bayer Chart

1 Month Bayer Chart

1 Month Bayer Chart